Clinical Trials Sponsored by Nucleix Ltd.

Total 17080 results

Nucleix Ltd.

Recruiting

Lung EpiCheck Biomarkers Development Study

Lung Cancer

United States, Israel, Hungary, Netherlands
Nucleix Ltd.

Completed

Characterization of Methylation Patterns in Lung Cancer

Lung Cancer

Israel
Nucleix Ltd.

Recruiting

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Lung Cancer

United States, Canada
Nucleix Ltd.

Completed

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

Non Muscle Invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma

United States
Nucleix Ltd.

Completed

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Cancer | Hematologic Neoplasms | Solid Tumor

Israel, United States
Nucleix Ltd.

Terminated

Characterization of Methylation Patterns in Hepatocellular Carcinoma

Hepatocellular Carcinoma | Cirrhosis | Hepatocellular Cancer

Israel
Nucleix Ltd.

Completed

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

Bladder Cancer

Netherlands, Israel, Germany, Spain
Nucleix Ltd.

Completed

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

Bladder Cancer

United States, Canada
Fundacio Puigvert
Nucleix Ltd.

Unknown

Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study

Urologic Neoplasms | Urologic Cancer

Spain
GlaxoSmithKline
Nucleus Network Ltd

Completed

Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects

Healthy Volunteers

Australia
Annexon, Inc.
Nucleus Network Ltd

Completed

A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

Safety and Tolerability in Healthy Volunteers

Australia
KAI Pharmaceuticals
Nucleus Network Ltd

Completed

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

Hyperparathyroidism, Secondary

Australia
Angion Biomedica Corp
Nucleus Network Ltd

Not yet recruiting

Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects

Hemodialysis

United States
Suzhou Connect Biopharmaceuticals, Ltd.
Tigermed Consulting Co., Ltd; Nucleus Network Ltd

Completed

Phase 1 Study Accessing the Safety and Tolerability of CBP-307

Autoimmune Diseases

Australia
Biosergen AS
Nucleus Network Ltd; Select Pharma Pty Ltd; Greenlight Clinical

Recruiting

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Invasive Fungal Infections

Australia
Medicines for Malaria Venture
Nucleus Network Ltd; Southern Star Research Pty Ltd.

Completed

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.

Malaria

Australia
Medicines for Malaria Venture
Syneos Health; Nucleus Network Ltd

Completed

Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

Healthy Volunteers

Australia
Medicines for Malaria Venture
Nucleus Network Ltd; Southern Star Research Pty Ltd.

Completed

Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine

Malaria

Australia
Medicines for Malaria Venture
Nucleus Network Ltd; Southern Star Research Pty Ltd.

Completed

MMV533 Plasmodium Falciparum Volunteer Infection Study

Malaria

Australia
Seattle Nuclear Medicine

Completed

F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases

Cancer | Bone Metastases

United States
Resverlogix Corp
Nucleus Network Ltd; Baker Heart and Diabetes Institute

Completed

The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes

Diabetes

Australia
Nuclear Medicine Consultants, Inc.

Unknown

Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours

Neuroendocrine Tumor

United States
Cocrystal Pharma, Inc.
Cocrystal Pharma Australia Pty Ltd.; Nucleus Network Pty Ltd.; Beyond Drug Development... and other collaborators

Recruiting

CDI-988 Safety Study in Healthy Participants

Healthy Volunteers

Australia
Red Nucleus Enterprise Solutions, LLC

Recruiting

NSAA NON-Interventional Study Protocol

Duchenne Muscular Dystrophy

United States
Nucleo de Plastica Avancada

Completed

Nautilus: Dynamic Craniotomy; New Surgical Technique and Preliminary Results (Nautilus)

Children With Craniosynostoses

Brazil
Institute of Nuclear Energy Research, Taiwan

Terminated

to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage

Tumors

Taiwan
Excel Diagnostics and Nuclear Oncology Center

Withdrawn

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (PUTNET)

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma | Unknown Primary Tumors | Pulmonary Neuroendocrine Neoplasm | Thymus Carcinoid | Neuroendocrine Skin Carcinoma | Neuroendocrine Breast Tumor | Neuroendocrine Carcinoma Metastatic | Neuroendocrine Neoplasm of Ovary

United States
Institute of Nuclear Energy Research, Taiwan

Completed

to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers

Safety Issues

Taiwan
China National Nuclear Corporation 416 Hospital

Unknown

Correlation Between Different Levels of Thyroid Peroxidase Antibody and Postpartum Thyroiditis in Early Pregnancy

Postpartum Thyroiditis

China
Institute of Nuclear Energy Research, Taiwan

Completed

to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

Hepatic Carcinoma

Taiwan
Nucleo Interdisciplinar da Ciencia do Sono

Completed

The Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure on Appearance and Age

Obstructive Sleep Apnea

Brazil
Excel Diagnostics and Nuclear Oncology Center
Radiomedix, Inc.

Completed

AminoMedixTM for Kidney Protection During Radionuclide Therapy

Radiation Nephropathy
Sociedad Española de Medicina Nuclear e Imagen...

Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177 (SEPTRALU)

Digestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Endocrine System Diseases | Stomach Neoplasms | Gastrointestinal Neoplasms | Digestive System Neoplasms | Neoplasms, Germ Cell and Embryonal | Endocrine Gland Neoplasms | Neuroectodermal Tumors | Neoplasms, Nerve Tissue | Intestinal Diseases and other conditions

Spain
University Ghent
Federal Agency for Nuclear Control, Belgium

Completed

Low Dose Effects of X-rays in Pediatric Patients Undergoing a CT Examination. (PedCTBe)

Pediatric Patients Undergoing a Computed Tomography Examination

Belgium
Wuxi People's Hospital
Jiangsu Institute of Nuclear Medicine

Unknown

Serological Screening of Gastric Cancer in Wuxi Region

Stomach Neoplasms
Asian Institute of Gastroenterology, India
KK Nuclear Scan

Completed

Gastric Emptying After Infracolic or Supracolic Gastrojejunostomy Following Pancreaticoduodenectomy

Postprocedural Gastric Stasis

India
Ebrahim S Delpassand
Excel Diagnostics and Nuclear Oncology Center

Completed

177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms

Neuroendocrine Tumors

United States
Tri-Service General Hospital
Institute of Nuclear Energy Research, Taiwan

Completed

The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD (STAPMDDTDM)

Major Depressive Disorder
Central Hospital, Nancy, France
GIE NANCYCLOTEP; Advanced Nuclear Medicine Ingredients (ANMI)

Unknown

Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer (TEPGALCHOL)

Prostate Cancer

France
Clinical Centre of Serbia
Center of nuclear medicine; Institute for histology

Unknown

Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients (PATA-STEMI)

Myocardial Infarction

Serbia
Mirka Ltd
Clinius Ltd

Completed

A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin

Keratosis, Actinic | Hyperkeratotic Callus | Actinic Lesion | Solar Keratosis/Sunburn | Hyperkeratosis | Hyperkeratotic; Lesion | Hyperkeratotic Actinic Keratosis

Finland
Salus Ltd.
TheraVitae Ltd.

Completed

Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease

Critical Limb Ischemia

Hungary
Janssen-Cilag Farmaceutica Ltda.
Janssen Korea, Ltd., Korea

No longer available

An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

Hong Kong, Brazil, Thailand
Jonsson Comprehensive Cancer Center
Society of Nuclear Medecine and Molecular Imaging

Recruiting

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Breast Carcinoma | Gastric Carcinoma | Head and Neck Carcinoma | Lung Carcinoma | Ovarian Carcinoma | Colon Carcinoma | Esophageal Carcinoma | Kidney Carcinoma | Pancreatic Carcinoma | Uterine Corpus Cancer | Solid Neoplasm

United States
Aarhus University Hospital Skejby
Department of Nuclear Medicine, Aarhus University Hospital

Active, not recruiting

The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan Based Absolute Myocardial Blood Flow in the Coronary Artery Territory (FLOW3)

Coronary Artery Disease

Denmark
Ology Bioservices
Pharm-Olam, LLC; Chemical, Biological, Radiological, and Nuclear Medical

Withdrawn

Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT) (COMBAAT)

Mild to Moderate COVID-19
Paion UK Ltd.
Chiltern International Ltd.; HFL Ltd.

Completed

An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours

Postoperative Pain

France, Germany, Netherlands, Poland, United Kingdom, Czechia
Cardiovalve Ltd.
Meditrial Europe Ltd.

Recruiting

Cardiovalve Transfemoral System - FIM Study

Mitral Regurgitation

Lithuania
Vensica Therapeutics Ltd.
Blueclinical, Ltd.

Completed

Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects (XAVIER)

Overactive Bladder

Portugal
Nanomedic Technologies Ltd.

Completed

Evaluation of the SpinCare™ System in the Treatment of Partial Thickness Burns (SPINCARE2)

Partial Thickness Burn

Israel

Clinical Trials Sponsored by Nucleix Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations